Katsumasa Kuroi

Summary

Country: Japan

Publications

  1. ncbi request reprint Pathophysiology of seroma in breast cancer
    Katsumasa Kuroi
    Department of Surgery, Showa University Toyosu Hospital, Koutou ku, Tokyo 135 8577, Japan
    Breast Cancer 12:288-93. 2005
  2. doi request reprint Prognostic significance of subtype and pathologic response in operable breast cancer; a pooled analysis of prospective neoadjuvant studies of JBCRG
    Katsumasa Kuroi
    Department of Surgery, Tokyo Metropolitan Cancer and Infectious Diseases Center Komagome Hospital, 3 18 22 Honkomagome, Bunkyo ku, Tokyo, 113 8677, Japan
    Breast Cancer 22:486-95. 2015
  3. pmc Comparison of different definitions of pathologic complete response in operable breast cancer: a pooled analysis of three prospective neoadjuvant studies of JBCRG
    Katsumasa Kuroi
    Department of Surgery, Tokyo Metropolitan Cancer and Infectious Diseases Center Komagome Hospital, 3 18 22 Honkomagome, Bunkyo ku, Tokyo, 113 8677, Japan
    Breast Cancer 22:586-95. 2015
  4. pmc Prediction of axillary lymph node metastasis in primary breast cancer patients using a decision tree-based model
    Masahiro Takada
    Department of Breast Surgery, Graduate School of Medicine, Kyoto University, Kyoto, Japan
    BMC Med Inform Decis Mak 12:54. 2012
  5. doi request reprint Prospective assessment of chemotherapy-induced peripheral neuropathy due to weekly paclitaxel in patients with advanced or metastatic breast cancer (CSP-HOR 02 study)
    Katsumasa Kuroi
    Department of Surgery, Division of Clinical Trials and Research, Tokyo Metropolitan Cancer and Infectious Disease Center Komagome Hospital, 3 18 22 Honkomagome, Bunkyo ku, Tokyo 113 8677, Japan
    Support Care Cancer 17:1071-80. 2009
  6. ncbi request reprint Circulating levels of endostatin in cancer patients
    K Kuroi
    Department of Surgery, Tokyo Metropolitan Komagome Hospital, Bunkyo ku, Tokyo 113 8677, Japan
    Oncol Rep 8:405-9. 2001
  7. doi request reprint A questionnaire survey of physicians' perspectives regarding the assessment of chemotherapy-induced peripheral neuropathy in patients with breast cancer
    Katsumasa Kuroi
    Division of Clinical Trials and Research, Department of Surgery, Tokyo Metropolitan Cancer and Infectious Disease Center Komagome Hospital, Tokyo, Japan
    Jpn J Clin Oncol 38:748-54. 2008
  8. ncbi request reprint Current status of health outcome assessment of medical treatment in breast cancer
    Katsumasa Kuroi
    Division of Surgery, Breast Oncology, Nyuwakai Oikawa Hospital, Fukuoka, Japan
    Breast Cancer 14:74-80. 2007
  9. ncbi request reprint Effect of mechanical closure of dead space on seroma formation after breast surgery
    Katsumasa Kuroi
    Department of Surgery, Breast Oncology, Medical Corporation Nyuwakai Oikawa Hospital, 2 21 16 Hirao, Chuo Ku, Fukuoka 810 0014, Japan
    Breast Cancer 13:260-5. 2006
  10. ncbi request reprint Evidence-based risk factors for seroma formation in breast surgery
    Katsumasa Kuroi
    Division of Surgery and Breast Oncology, Nyuwakai Oikawa Hospital, 2 21 16 Hirao, Chuo Ku, Fukuoka 810 0014, Japan
    Jpn J Clin Oncol 36:197-206. 2006

Detail Information

Publications32

  1. ncbi request reprint Pathophysiology of seroma in breast cancer
    Katsumasa Kuroi
    Department of Surgery, Showa University Toyosu Hospital, Koutou ku, Tokyo 135 8577, Japan
    Breast Cancer 12:288-93. 2005
    ..Seroma is the most common complication of mastectomy. The aim of this systematic review is to clarify the pathophysiology of seroma...
  2. doi request reprint Prognostic significance of subtype and pathologic response in operable breast cancer; a pooled analysis of prospective neoadjuvant studies of JBCRG
    Katsumasa Kuroi
    Department of Surgery, Tokyo Metropolitan Cancer and Infectious Diseases Center Komagome Hospital, 3 18 22 Honkomagome, Bunkyo ku, Tokyo, 113 8677, Japan
    Breast Cancer 22:486-95. 2015
    ..The present study is a pooled analysis of these studies performed to determine the prognostic significance of pathologic complete response (pCR) and predictive variables for pCR...
  3. pmc Comparison of different definitions of pathologic complete response in operable breast cancer: a pooled analysis of three prospective neoadjuvant studies of JBCRG
    Katsumasa Kuroi
    Department of Surgery, Tokyo Metropolitan Cancer and Infectious Diseases Center Komagome Hospital, 3 18 22 Honkomagome, Bunkyo ku, Tokyo, 113 8677, Japan
    Breast Cancer 22:586-95. 2015
    ..Neoadjuvant chemotherapy (NAC) has been accepted as one of the standard treatments for operable breast cancer. However, the term pathologic complete response (pCR) has not been consistently defined...
  4. pmc Prediction of axillary lymph node metastasis in primary breast cancer patients using a decision tree-based model
    Masahiro Takada
    Department of Breast Surgery, Graduate School of Medicine, Kyoto University, Kyoto, Japan
    BMC Med Inform Decis Mak 12:54. 2012
    ..The aim of this study was to develop a new data-mining model to predict axillary lymph node (AxLN) metastasis in primary breast cancer. To achieve this, we used a decision tree-based prediction method-the alternating decision tree (ADTree)...
  5. doi request reprint Prospective assessment of chemotherapy-induced peripheral neuropathy due to weekly paclitaxel in patients with advanced or metastatic breast cancer (CSP-HOR 02 study)
    Katsumasa Kuroi
    Department of Surgery, Division of Clinical Trials and Research, Tokyo Metropolitan Cancer and Infectious Disease Center Komagome Hospital, 3 18 22 Honkomagome, Bunkyo ku, Tokyo 113 8677, Japan
    Support Care Cancer 17:1071-80. 2009
    ....
  6. ncbi request reprint Circulating levels of endostatin in cancer patients
    K Kuroi
    Department of Surgery, Tokyo Metropolitan Komagome Hospital, Bunkyo ku, Tokyo 113 8677, Japan
    Oncol Rep 8:405-9. 2001
    ..05, log-rank test). Our data demonstrate that PESLs are detectable in healthy controls, and that cancer patients have elevated PESLs. A larger study is warranted to clarify the clinical significance of circulating endostatin...
  7. doi request reprint A questionnaire survey of physicians' perspectives regarding the assessment of chemotherapy-induced peripheral neuropathy in patients with breast cancer
    Katsumasa Kuroi
    Division of Clinical Trials and Research, Department of Surgery, Tokyo Metropolitan Cancer and Infectious Disease Center Komagome Hospital, Tokyo, Japan
    Jpn J Clin Oncol 38:748-54. 2008
    ..The aim of this study was to evaluate the physicians' perspectives regarding the utility and diagnostic value of PNQ...
  8. ncbi request reprint Current status of health outcome assessment of medical treatment in breast cancer
    Katsumasa Kuroi
    Division of Surgery, Breast Oncology, Nyuwakai Oikawa Hospital, Fukuoka, Japan
    Breast Cancer 14:74-80. 2007
    ..We also review the current status of HR-QOL assessment of medical treatment in breast cancer...
  9. ncbi request reprint Effect of mechanical closure of dead space on seroma formation after breast surgery
    Katsumasa Kuroi
    Department of Surgery, Breast Oncology, Medical Corporation Nyuwakai Oikawa Hospital, 2 21 16 Hirao, Chuo Ku, Fukuoka 810 0014, Japan
    Breast Cancer 13:260-5. 2006
    ..However, previous studies have often been small in scale and poor in quality. Further studies should examine the effect of this technique on quality of life, cosmesis, and medical economics...
  10. ncbi request reprint Evidence-based risk factors for seroma formation in breast surgery
    Katsumasa Kuroi
    Division of Surgery and Breast Oncology, Nyuwakai Oikawa Hospital, 2 21 16 Hirao, Chuo Ku, Fukuoka 810 0014, Japan
    Jpn J Clin Oncol 36:197-206. 2006
    ..Seroma is a common problem in breast surgery. The aim of this systematic review was to identify risk factors for seroma formation...
  11. ncbi request reprint Circulating angiogenesis regulators in cancer patients
    K Kuroi
    Department of Surgery, Tokyo Metropolitan Komagome Hospital, Japan
    Int J Biol Markers 16:5-26. 2001
    ....
  12. ncbi request reprint Clinical significance of plasma nucleosome levels in cancer patients
    K Kuroi
    Department of Surgery, Tokyo Metropolitan Komagome Hospital, 3 18 22 Honkomagome, Bunkyo ku, Tokyo 113 8677, Japan
    Int J Oncol 19:143-8. 2001
    ..Thus, increased PNLs were found in cancer patients, and PNLs seem to be a sensitive marker of cell death that could be predictive of both leukopenia and response to chemotherapy...
  13. ncbi request reprint Weekly schedule of docetaxel in breast cancer: evaluation of response and toxicity
    Katsumasa Kuroi
    Department of Surgery, Toyosu Hospital Showa University, 4 1 18 Toyosu, Koutou ku, Tokyo 135 8577, Japan
    Breast Cancer 10:10-4. 2003
    ..However, there is still much to learn about the role of weekly docetaxel in adjuvant and neoadjuvant therapy...
  14. ncbi request reprint Metastasis of breast carcinoma to rectus abdominis muscle
    Katsumasa Kuroi
    Breast Cancer Center, Toyosu Hospital Showa University, Koutou ku, Tokyo, Japan
    Breast J 9:58-9. 2003
  15. ncbi request reprint Protracted administration of weekly docetaxel in metastatic breast cancer
    Katsumasa Kuroi
    Department of Surgery, Showa University Toyosu Hospital, Tokyo 135 8577, Japan
    Oncol Rep 10:1479-84. 2003
    ..Thus, a weekly schedule of docetaxel at low dose maintains activity and is less myelosuppressive, however, one should be careful about cumulative toxicities...
  16. pmc Flare hypercalcemia after letrozole in a patient with liver metastasis from breast cancer: a case report
    Katsumasa Kuroi
    Department of Surgery, Tokyo Metropolitan Cancer and Infectious Diseases Center Komagome Hospital, 3 18 22 Honkomagome, Bunkyo ku, Tokyo 113 8677, Japan
    J Med Case Rep 5:495. 2011
    ..Tamoxifen may occasionally precipitate serious and potentially life-threatening hypercalcemia. However, to date, this has not been documented with aromatase inhibitors...
  17. ncbi request reprint [Predictors of axillary node metastasis at breast surgery after neoadjuvant chemotherapy in patients with pre- chemotherapy-sentinel node positive breast cancer]
    Hiromi Tokita
    Department of Breast Surgery, Tokyo Metropolitan Cancer and Infectious Diseases Center Komagome Hospital, Tokyo, Japan
    Gan To Kagaku Ryoho 38:1639-45. 2011
    ..We investigated predictors for axillary node metastasis at breast surgery after neoadjuvant chemotherapy (NAC) in patients with pre-chemotherapy-sentinel node positive breast cancer...
  18. ncbi request reprint Predictive value of CD24 and CD44 for neoadjuvant chemotherapy response and prognosis in primary breast cancer patients
    Kazumi Horiguchi
    Department of Human Pathology, Tokyo Medical and Dental University Graduate School, Tokyo, Japan
    J Med Dent Sci 57:165-75. 2010
    ..We investigated the significance of CD24 and CD44 expression for predicting responses to chemotherapy and prognosis in primary breast cancer patients...
  19. doi request reprint Clinicopathological analysis of ten patients with metaplastic squamous cell carcinoma of the breast
    Michitaka Honda
    Department of Breast Surgery, Tokyo Metropolitan Komagome Hospital, 3 18 22 Honkomagome, Bunkyo ku, Tokyo, 113 8677, Japan
    Surg Today 41:328-32. 2011
    ..This is a retrospective study of patients in a single center with SCC or MSCC...
  20. doi request reprint Relationship between body mass index and preoperative treatment response to aromatase inhibitor exemestane in postmenopausal patients with primary breast cancer
    Masahiro Takada
    Department of Surgery, Graduate School of Medicine, Kyoto University, Japan
    Breast 21:40-5. 2012
    ..We aimed to investigate predictive effect of BMI on clinical response to neoadjuvant therapy with exemestane in postmenopausal patients with primary breast cancer...
  21. doi request reprint Effect of low-dose Paclitaxel and docetaxel on endothelial progenitor cells
    Mariko Muta
    Department of Health and Dietetics, Faculty of Medical Health, Teikyo Heisei University, Tokyo, Japan
    Oncology 77:182-91. 2009
    ..We aimed to clarify the cytotoxic and inhibitory effects of these drugs on EPC...
  22. doi request reprint Multi-center study evaluating circulating tumor cells as a surrogate for response to treatment and overall survival in metastatic breast cancer
    Seigo Nakamura
    Department of Breast Surgical Oncology, St Luke s International Hospital, Chuo Ku, Tokyo, Japan
    Breast Cancer 17:199-204. 2010
    ..In this prospective study, we evaluated CTCs in predicting treatment efficacy and overall survival (OS) using the CellSearch System (Veridex, LLC, Raritan, NJ)...
  23. pmc Invasive papillary carcinoma treated with neoadjuvant endocrine therapy in which pathological complete response was achieved
    Chiaki Saita
    Department of Surgery, Tokyo Metropolitan Cancer and Infectious Diseases Center Komagome Hospital, 3 18 22 Honkomagome, Bunkyo ku, Tokyo, 113 8677, Japan
    BMC Res Notes 9:46. 2016
    ..Neoadjuvant endocrine therapy is now considered as an optional therapy for postmenopausal women with hormone receptor-positive breast cancers, including invasive papillary carcinoma...
  24. doi request reprint Sex steroid hormones in pairs of tumor and serum from breast cancer patients and pathobiological role of androstene-3β, 17β-diol
    Naoko Honma
    Research Team for Geriatric Pathology, Tokyo Metropolitan Institute of Gerontology, Tokyo, Japan
    Cancer Sci 102:1848-54. 2011
    ..The intratumoral increase of E2, but not E1, in hormone receptor-positive postmenopausal breast cancer tissue, as well as the proliferative role of Aenediol, was elucidated...
  25. ncbi request reprint A low number of tumor-infiltrating FOXP3-positive cells during primary systemic chemotherapy correlates with favorable anti-tumor response in patients with breast cancer
    Tomoyuki Aruga
    Department of Surgery, Tokyo Metropolitan Cancer and Infectious Diseases Center Komagome Hospital, Tokyo 113 8677, Japan
    Oncol Rep 22:273-8. 2009
    ..These findings suggest that the number of FOXP3-positive cells identified during PSC represents a promising predictive factor that might also be an important therapeutic target for breast cancer...
  26. ncbi request reprint Neurotoxicity of taxanes: symptoms and quality of life assessment
    Katsumasa Kuroi
    Department of Surgery, Showa University, Toyosu Hospital, 4 1 18 Toyosu, Koutou ku, Tokyo 135 8577, Japan
    Breast Cancer 11:92-9. 2004
    ..This will enable us to provide the information that patients require when treatment decisions are being made, and will help in the pursuit of the ameliorative interventions...
  27. doi request reprint Evaluation of the Clinical Utility of the ICG Fluorescence Method Compared with the Radioisotope Method for Sentinel Lymph Node Biopsy in Breast Cancer
    Tomoharu Sugie
    Department of Surgery, Kansai Medical University, Hirakata, Japan
    Ann Surg Oncol 23:44-50. 2016
    ..This study compared the clinical utility of indocyanine green (ICG) fluorescence and radioisotope (RI) for sentinel lymph node (SLN) detection in breast cancer...
  28. doi request reprint Prolonged survival after diagnosis of brain metastasis from breast cancer: contributing factors and treatment implications
    Yayoi Honda
    Division of Breast Surgery, Tokyo Metropolitan Cancer and Infectious Diseases Center, Komagome Hospital, Tokyo, Japan
    Jpn J Clin Oncol 45:713-8. 2015
    ..In a retrospective study, we examined prognostic factors in patients with breast cancer-derived brain metastasis, and we tested the prognostic utility of a breast cancer-specific Graded Prognostic Assessment in these patients...
  29. pmc An overview of the Japan Breast Cancer Research Group (JBCRG) activities
    Shinji Ohno
    Department of Breast Oncology, National Kyushu Cancer Center, Notame 3 1 1 Minami ku, Fukuoka, 811 1395, Japan
    Breast Cancer 20:291-5. 2013
    ..The JBCRG implements international collaboration in some researches/studies. As of January 2012, fourteen trials have been closed and nine are open to recruitment. ..
  30. ncbi request reprint HER-2/neu cytoplasmic staining is correlated with neuroendocrine differentiation in breast carcinoma
    Shin Ichiro Horiguchi
    Department of Human Pathology, Tokyo Medical and Dental University Graduate School, Tokyo, Japan
    J Med Dent Sci 57:155-63. 2010
    ..Although the result is preliminary, it warrants further study on the role of the cytoplasmic variant form of HER2 in breast cancer growth, particularly in the aspect of neuroendocrine differentiation...
  31. doi request reprint Efficacy and safety of low-dose capecitabine plus docetaxel versus single-agent docetaxel in patients with anthracycline-pretreated HER2-negative metastatic breast cancer: results from the randomized phase III JO21095 trial
    Daigo Yamamoto
    Department of Surgery, Kansai Medical University Medical Center, 10 15 Fumizono cho, Moriguchi City, Osaka, 570 8507, Japan
    Breast Cancer Res Treat . 2016
    ....
  32. doi request reprint Application of selective estrogen receptor modulators for breast cancer treatment according to their intrinsic nature
    Shigehira Saji
    Division of Clinical Trials and Research, Department of Breast Surgery and Oncology, Tokyo Metropolitan Cancer and Infectious Diseases Center Komagome Hospital, Bunkyo ku, Tokyo, Japan
    Breast Cancer 15:262-9. 2008
    ..There were several reports showing the antiproliferative effect of SERMs for estrogen receptor-negative cells, such as glioma. There are still numerous possible applications for SERMs when their intrinsic nature is utilized...